Entera Bio Ltd (NASDAQ:ENTX)
| 2.41 Delayed Data As of Mar 26 |  0.00 / 0.00%Today’s Change | 1.35 Today|||52-Week Range 4.40 | +12.62% Year-to-Date |
Latest ENTX News | Press Releases
No recent news for Entera Bio Ltd.
Today’s Trading
| Previous close | 2.41 |
| Today’s open | 2.29 |
| Day’s range | 2.29 - 2.41 |
| Volume | 0 |
| Average volume (3 months) | 12,281 |
| Market cap | $43.3M |
Data as of 1:46pm ET, 03/26/2020
Growth & Valuation
| Earnings growth (last year) | -34.62% |
| Earnings growth (this year) | +38.17% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 48.53 |
| Price/Book | 2.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONCTOncternal Therapeuti... | -0.02 | -0.71% |
| NNVCNanoViricides Inc | +0.06 | +1.08% |
| ONTXOnconova Therapeutic... | -0.01 | -4.03% |
| MDWDMediwound Ltd | -0.04 | -2.37% |
Data as of 4:00pm ET, 03/27/2020
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $500.0K |
| Annual profit (last year) | -$10.3M |
| Net profit margin | -2,060.80% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
